Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allevion Medical is a private medical technology company focused on minimally invasive spinal care. The company develops single-use, sterile spinal decompression systems intended to simplify procedures, improve visualization, and reduce operational complexity for surgeons and care sites. Its lead product, Vantage, received FDA 510(k) clearance in April 2026 for minimally invasive lumbar decompression procedures associated with hypertrophic bone growth. Allevion positions Vantage as a fully disposable system with integrated illumination, direct visualization, and a structured workflow designed for use in ambulatory surgery centers and hospitals. The company appears to be focused on spine medtech rather than therapeutics, with a product-centered portfolio built around procedural efficiency, safety, and precision.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allevion Medical.